VistaGen Therapeutics Receives $1,930,281 New Funding

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=416e639a-1b4b-4e7a-a988-0cb30dcf2968
Date
8/6/2015
Company Name
VistaGen Therapeutics
Mailing Address
343 Allerton Avenue South San Francisco, CA 94080 USA
Company Description
VistaGen Therapeutics is a biopharmaceutical company pioneering the use of embryonic stem cells (ES cells) for drug discovery and development and predictive toxicology.
Website
http://www.vistagen.com
Transaction Type
Venture Equity
Transaction Amount
$1,930,281
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
M&A Terms
Venture Investor
Undisclosed